35 related articles for article (PubMed ID: 26042518)
1. Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.
Nayor M; Wang N; Larson MG; Vasan RS; Levy D; Ho JE
J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722123
[TBL] [Abstract][Full Text] [Related]
2. Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance.
Zhang Z; Wang P; Guo F; Liu X; Luo T; Guan Y; Chen H; Wang Z; Zhao L; Ma X; Lv Q; Zhang Y; Kang J; Liu T; Liu X; Dong JZ; Bai R
J Int Med Res; 2018 Sep; 46(9):3959-3969. PubMed ID: 29968484
[TBL] [Abstract][Full Text] [Related]
3. Genetic association study identifies genetic variants for non-alcoholic fatty liver without comorbidities in the Korean population.
Kim YJ; Cho YS
Genes Genomics; 2023 Jul; 45(7):847-854. PubMed ID: 37133724
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle and Quality of Life of Women Diagnosed with Hypothyroidism in the Context of Non-Alcoholic Fatty Liver.
Janota B; Adamek B; Szczepańska E; Biernacki K; Janczewska E
Metabolites; 2023 Nov; 13(12):. PubMed ID: 38132856
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Lifestyle Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Relationship with Premature Coronary Artery Disease: A Study on the Pars Cohort.
Anushiravani A; Rayatpisheh M; Kasaeian A; Menbari Oskouie I
Arch Iran Med; 2024 May; 27(5):248-254. PubMed ID: 38690791
[TBL] [Abstract][Full Text] [Related]
6. A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis.
Motamed N; Zamani F; Maadi M; Ajdarkosh H; Roozafzai F; Keyvani H; Poustchi H; Shakeri R; Ashrafi GH; Perumal D; Rabiee B; Moradi-Lakeh M; Khoonsari M; Kheyri Z; Sohrabi MR; Doustmohammadian A; Amirkalali B; Safarnezhad Tameshkel F; Gholizadeh E; Hosseini SH; Karbalaie Niya MH
Front Endocrinol (Lausanne); 2024; 15():1329380. PubMed ID: 38681770
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.
Tabaeian SP; Rezapour A; Azari S; Martini M; Saran M; Behzadifar M; Shahabi S; Sayyad A; Tahernejad A; Bragazzi NL; Ehsanzadeh SJ; Behzadifar M
J Clin Exp Hepatol; 2024; 14(1):101209. PubMed ID: 38076354
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis.
Hassanipour S; Amini-Salehi E; Joukar F; Khosousi MJ; Pourtaghi F; Ansar MM; Mahdavi-Roshan M; Heidarzad F; Rashidi-Mojdehi G; Abdzadeh E; Vakilpour A; Mansour-Ghanaei F
Iran J Public Health; 2023 Aug; 52(8):1600-1612. PubMed ID: 37744533
[TBL] [Abstract][Full Text] [Related]
9. Association between central obesity and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.
Cao C; Hu H; Zheng X; Zhang X; Wang Y; He Y
Sci Rep; 2022 Aug; 12(1):13445. PubMed ID: 35927472
[TBL] [Abstract][Full Text] [Related]
10. Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases.
Mokhtari F; Mohebbi SR; Sharifian A; Ramandi M; Razzaghi MR
Gastroenterol Hepatol Bed Bench; 2021; 14(Suppl1):S10-S23. PubMed ID: 35154598
[TBL] [Abstract][Full Text] [Related]
11. HbA
Masroor M; Haque Z
J Clin Transl Hepatol; 2021 Feb; 9(1):15-21. PubMed ID: 33604251
[TBL] [Abstract][Full Text] [Related]
12. Burden of Liver Diseases: A Review from Iran.
Anushiravani A; Ghajarieh Sepanlou S
Middle East J Dig Dis; 2019 Oct; 11(4):189-191. PubMed ID: 31824620
[TBL] [Abstract][Full Text] [Related]
13. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
14. The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS).
Mansour-Ghanaei R; Mansour-Ghanaei F; Naghipour M; Joukar F; Atrkar-Roushan Z; Tabatabaii M; Ghorani N
J Med Life; 2018; 11(3):194-202. PubMed ID: 30364682
[No Abstract] [Full Text] [Related]
15. Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.
Moghaddasifar I; Lankarani KB; Moosazadeh M; Afshari M; Ghaemi A; Aliramezany M; Afsar Gharebagh R; Malary M
Int J Organ Transplant Med; 2016; 7(3):149-160. PubMed ID: 27721961
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study.
Ostovaneh MR; Zamani F; Ansari-Moghaddam A; Sharafkhah M; Saeedian FS; Rohani Z; Khoonsari M; Barzin G; Hemmasi G; Ajdarkosh H; Katoonizadeh A; Maadi M; Malekzadeh R; Poustchi H
Metab Syndr Relat Disord; 2015 Sep; 13(7):304-11. PubMed ID: 26042518
[TBL] [Abstract][Full Text] [Related]
17. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
18. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.
Pang Q; Zhang JY; Song SD; Qu K; Xu XS; Liu SS; Liu C
World J Gastroenterol; 2015 Feb; 21(5):1650-62. PubMed ID: 25663786
[TBL] [Abstract][Full Text] [Related]
19. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
